• • 
1.\ re:vieu e,f FBI files frtr infnrmatinn rclatinz 
tn drugs designed t-, m~dify behavior indicates an 
interest dating back t~ 1922. However. this interest 
has Mt extended t.n the pl')int "t-7here the FBI has cnnductcd 
procrams invnlvin::; roscarch 1 e..'Cperimento.tiNl nr uoc ttf 
drugs fnr interr"'gatinn purpt"\ses. Ueither has it funded 
such programs. Ue have maintained lia.isnn u:tth nther 
u. s. C!')vornment agencies and industrial l)rganizatit\ns 
in nrder tn be awa~e of develnpments in this a~ea. 
H,,wever, ue have n<'\t inq,lemanted any p1:ograms to apply 
the results ~f research cf)nclucted by such ~rganizatinns. 
1 - The Attorney General 
NOTE: 
The FBI representative who reviewed the Navy 
records uas Supervisor J.P. Thomas, Intelligence Division; 
results reported in memorandum U. n. Cregar to Mr. W.R. 
Wannall, 11/6/75, entitled nsenst\ldy 75." The Senate 
Judiciary Subcommittee has previously been advised that 
available Bureau records and interview with current 
knowledgeable employee indicate that the FBI has never 
engaged in or funded anyone's efforts in research and/or 
development programs in the use or effect of drugs nn 
human behavior. This information is recorded in memorandum 
from Mr. J. Cochran, Jr.> to Mr. T. J. Jenkins, dated 
11/28/75, entitled "Request by Senate Judiciary Subcommittee 
on Administrative Practice and Procedure for Information 
Concerning Use of Drugs for Interrogation." A copy of 
the communication being furnished herewith is being 
maintained in the Senstudy Unit> Intelligence Division. 
A copy of the 11/21/75 SSC request is attached to the 
file copy of this LHM. 
- 2 -
L NW 38608 Docld:32989570 30 
